Influence of Liver Pathologies on the Development and Progression of Breast Cancer: Pathophysiological Mechanisms, Therapeutic Strategies and Prevention

This article analyzes the relationship between liver pathologies and breast cancer (BC). We consider the pathophysiological mechanisms underlying this relationship, including the influence of non-alcoholic fatty liver disease (NAFLD), drug-induced liver injury (DILI), and estrogen metabolism disorders. Particular attention is paid to the molecular pathways that contribute to the development of BC against the background of liver pathologies. An overview of modern therapeutic and preventive strategies for women with identified liver pathologies, as well as for women with liver pathologies and the first signs of BC is presented. The article describes drugs with confirmed efficacy based on international studies, and also provides recommendations on diet and regimen that help improve the prognosis of survival.

Authors

Institutions

Publication Details

Journal
Antibiot Khimioter = Antibiotics and Chemotherapy
Published
2025-08-08
DOI
https://doi.org/10.37489/0235-2990-2025-70-5-6-52-57
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Influence of Liver Pathologies on the Development and Progression of Breast Cancer: Pathophysiological Mechanisms, Therapeutic Strategies and Prevention

З. А. Камбачокова, A. A. Kambachokova, A. S. Vologirov, Ruslan Mamedov et al.
Antibiot Khimioter = Antibiotics and Chemotherapy
Liver Disease Diagnosis and Treatment
article

Influence of Liver Pathologies on the Development and Progression of Breast Cancer: Pathophysiological Mechanisms, Therapeutic Strategies and Prevention

З. А. Камбачокова, A. A. Kambachokova, A. S. Vologirov, Ruslan Mamedov, Z. Kh. Makhieva, A. Kh. Betuganova, A. A. Zhakova, Z. Kh. Gadieva
article en

Abstract

This article analyzes the relationship between liver pathologies and breast cancer (BC). We consider the pathophysiological mechanisms underlying this relationship, including the influence of non-alcoholic fatty liver disease (NAFLD), drug-induced liver injury (DILI), and estrogen metabolism disorders. Particular attention is paid to the molecular pathways that contribute to the development of BC against the background of liver pathologies. An overview of modern therapeutic and preventive strategies for women with identified liver pathologies, as well as for women with liver pathologies and the first signs of BC is presented. The article describes drugs with confirmed efficacy based on international studies, and also provides recommendations on diet and regimen that help improve the prognosis of survival.

Antibiot Khimioter = Antibiotics and ChemotherapyVol. 70(5-6)
Kabardino-Balkarian State University (RU)
Good health and well-being
Openalex Percentile: Top 71%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.